Longeveron (LGVN) Total Current Liabilities (2021 - 2026)

Longeveron (LGVN) recorded quarterly Total Current Liabilities of $4.3 million in Q1 2026, up 6.31% quarter-over-quarter from $4.1 million in Q4 2025, and up 59.51% on a YoY basis from $2.7 million in Q1 2025.

Longeveron (LGVN) Total Current Liabilities (2021 - 2026) Analysis & Trends

Longeveron's Total Current Liabilities history runs 6 years deep, the most recent figure standing at $4.3 million for Q1 2026.

  • In Q1 2026, Total Current Liabilities rose 59.51% year-over-year to $4.3 million; the TTM figure through Mar 2026 stood at $4.3 million (up 59.51% YoY), while the FY2025 annual figure was $4.1 million, up 58.29% from the prior year.
  • Total Current Liabilities was $4.3 million for Q1 2026 at Longeveron, up from $4.1 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $5.3 million in Q1 2024 to a low of $2.6 million in Q4 2024.
  • Historically, Total Current Liabilities has averaged $3.8 million across 5 years, with a median of $3.7 million in 2023.
  • The sharpest annual moves came in 2022 and 2025: Total Current Liabilities jumped 79.8% in 2022, then slumped 48.56% in 2025.
  • A 5-year view of Total Current Liabilities shows it stood at $4.9 million in 2022, then decreased by 20.13% to $3.9 million in 2023, then plunged by 33.61% to $2.6 million in 2024, then soared by 58.29% to $4.1 million in 2025, then advanced by 6.31% to $4.3 million in 2026.
  • The last three Total Current Liabilities figures came in at $4.3 million (Q1 2026), $4.1 million (Q4 2025), and $4.9 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 1.70 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 16.35 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 636.40 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 13.42 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 3.88 Bn
9 Abivax 91.96 Bn 91.96 Bn - 72.86 Mn
10 Longeveron 20.35 Bn 20.33 Bn 264,000.00 4.35 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 4.35 Mn
Dec 31, 2025 4.09 Mn
Sep 30, 2025 4.94 Mn
Jun 30, 2025 3.28 Mn
Mar 31, 2025 2.72 Mn
Dec 31, 2024 2.58 Mn
Sep 30, 2024 3.10 Mn
Jun 30, 2024 3.21 Mn
Mar 31, 2024 5.30 Mn
Dec 31, 2023 3.89 Mn
Sep 30, 2023 3.39 Mn
Jun 30, 2023 4.08 Mn
Mar 31, 2023 3.60 Mn
Dec 31, 2022 4.87 Mn
Dec 31, 2021 2.71 Mn